what drugs are glp-1 Costs Explained: Managing Coverage Challenges GLP-1 Receptor Agonist Market Size
Description
De Herder Klppel
For the treatment of obesity, GLP-1RAs and GIP/ GLP-1RAs are indicated in patients with a body mass index (BMI) 30 kg m 2 , or 27 kg m 2 in the presence of at least one weight-related comorbidity, to support weight reduction [23]
doi: 10.1111/bph.v174.7 20 ZhuBGongNFanHPengCSDingXJJiangYet al
stands as the foremost national market for GLP1 receptor agonists, fueled by its sophisticated healthcare infrastructure, effective reimbursement mechanisms, and aggressive public awareness campaigns
doi: 10.1900/RDS.2014.11.181
